West Pharmaceutical Services Other Long-Term Assets 2010-2024 | WST

West Pharmaceutical Services other long-term assets for the quarter ending September 30, 2024 were $0.069B, a 78.61% increase year-over-year.

  • West Pharmaceutical Services other long-term assets for 2023 were $0.021B, a 44.53% decline from 2022.
  • West Pharmaceutical Services other long-term assets for 2022 were $0.038B, a 2.04% decline from 2021.
  • West Pharmaceutical Services other long-term assets for 2021 were $0.039B, a 67.52% increase from 2020.

West Pharmaceutical Services Other Long-Term Assets 2010-2024 | WST

  • West Pharmaceutical Services other long-term assets for 2023 were $0.021B, a 44.53% decline from 2022.
  • West Pharmaceutical Services other long-term assets for 2022 were $0.038B, a 2.04% decline from 2021.
  • West Pharmaceutical Services other long-term assets for 2021 were $0.039B, a 67.52% increase from 2020.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$79.1B
Becton Dickinson (BDX)$64.7B
Cardinal Health (CAH)$29.5B
Cooper (COO)$20.1B
Labcorp (LH)$20B
Align Technology (ALGN)$16.9B
Henry Schein (HSIC)$9.4B
Merit Medical Systems (MMSI)$6.1B
DENTSPLY SIRONA (XRAY)$3.7B
CONMED (CNMD)$2.3B
Patterson (PDCO)$1.8B
STAAR Surgical (STAA)$1.3B
Lifevantage (LFVN)$178M
Pro-Dex (PDEX)$152M